{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:11:30Z","timestamp":1772500290321,"version":"3.50.1"},"reference-count":106,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Peritoneal dialysis (PD) has been established as an essential renal replacement therapy for patients with end stage renal disease during the past half century. Histological evaluation of the peritoneal membrane has contributed to the pathophysiological understanding of PD-related peritoneal injury such as peritonitis, fibrosis, and encapsulating peritoneal sclerosis (EPS). Hyalinizing peritoneal sclerosis (HPS), also known as simple sclerosis, is observed in almost all of PD patients. HPS is morphologically characterized by fibrosis of the submesothelial interstitium and hyalinizing vascular wall, particularly of the post-capillary venule (PCV). Two histological factors, the thickness of submesothelial compact zone (SMC) and the lumen\/vessel ratio (L\/V) at the PCV, have been used for the quantitative evaluation of HPS. The measuring system on SMC thickness and L\/V ratio is easy and useful for evaluating the severity of HPS. On the other hand, EPS is characterized by unique encapsulation of the intestines by an \u201cencapsulating membrane\u201d. This newly formed membranous structure covers the visceral peritoneum of the intestines, which contains fibrin deposition, angiogenesis, and proliferation of fibroblast-like cells and other inflammatory cells. This review will cover the common understandings of PD-related peritoneal alterations and provide a basic platform for clinical applications and future studies in this field.<\/jats:p>","DOI":"10.1515\/pp-2016-0028","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T19:29:58Z","timestamp":1489865398000},"page":"3-15","source":"Crossref","is-referenced-by-count":11,"title":["Recommendations for pathological diagnosis on biopsy samples from peritoneal dialysis patients"],"prefix":"10.1515","volume":"2","author":[{"given":"Kunio","family":"Kawanishi","sequence":"first","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0687, USA"},{"name":"Department of Surgical Pathology, Tokyo Women\u2019s Medical University, 8-1, Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuho","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Showa University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieko","family":"Hamada","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"key":"2025120909184549810_j_pp-2016-0028_ref_001_w2aab3b7b7b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"1. Di Paolo N, Sacchi G, De Mia M, Gaggiotti E, Capotondo L, Rossi P, et al. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986;44:204\u201311.","DOI":"10.1159\/000183987"},{"key":"2025120909184549810_j_pp-2016-0028_ref_002_w2aab3b7b7b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"2. Gotloib L, Shostak A. Ultrastructural morphology of the peritoneum: New findings and speculations on transfer of solutes and water during peritoneal dialysis. Perit Dial Bull 1987;7:119\u201329.","DOI":"10.1177\/089686088700700304"},{"key":"2025120909184549810_j_pp-2016-0028_ref_003_w2aab3b7b7b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"3. Dobbie JW. Morphology of the peritoneum in CAPD. Blood Purif 1989;7:74\u201385.","DOI":"10.1159\/000169580"},{"key":"2025120909184549810_j_pp-2016-0028_ref_004_w2aab3b7b7b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"4. Honda K, Nitta K, Horita S, Yumura W, Nihei H. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996;72:171\u20136.","DOI":"10.1159\/000188837"},{"key":"2025120909184549810_j_pp-2016-0028_ref_005_w2aab3b7b7b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"5. Mateijsen MA, Van Der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999;19:517\u201325.","DOI":"10.1177\/089686089901900605"},{"key":"2025120909184549810_j_pp-2016-0028_ref_006_w2aab3b7b7b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"6. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al., Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002;13:470\u20139.","DOI":"10.1681\/ASN.V132470"},{"key":"2025120909184549810_j_pp-2016-0028_ref_007_w2aab3b7b7b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"7. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kid Dis 1996;28:420\u20137.","DOI":"10.1016\/S0272-6386(96)90501-6"},{"key":"2025120909184549810_j_pp-2016-0028_ref_008_w2aab3b7b7b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"8. Rigby RJ, Hawley CM. Sclerosing peritonitis: The experience in Australia. Nephrol Dial Transplant 1998;13:154\u20139.","DOI":"10.1093\/ndt\/13.1.154"},{"key":"2025120909184549810_j_pp-2016-0028_ref_009_w2aab3b7b7b1b6b1ab2b1b9Aa","unstructured":"9. Lee HY, Kim BS, Choi HY, Park HC, Kang SW, Choi KH, et al. Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea. Nephrology (Carlton) 2003;8:S33\u2013S39."},{"key":"2025120909184549810_j_pp-2016-0028_ref_010_w2aab3b7b7b1b6b1ab2b1c10Aa","unstructured":"10. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: Definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000;20:S43\u2013S55."},{"key":"2025120909184549810_j_pp-2016-0028_ref_011_w2aab3b7b7b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"11. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: A prospective, controlled, multicenter study. Am J Kidney Dis 2004;44:729\u201337.","DOI":"10.1016\/S0272-6386(04)00953-9"},{"key":"2025120909184549810_j_pp-2016-0028_ref_012_w2aab3b7b7b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"12. Summers AM, Clancy MJ, Syed F, Harwood N, Brenchley PE, Augustine T, et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int 2005;68:2381\u20138.","DOI":"10.1111\/j.1523-1755.2005.00701.x"},{"key":"2025120909184549810_j_pp-2016-0028_ref_013_w2aab3b7b7b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"13. Brown MC, Simpson K, Kerssens JJ, Mactier RA, Scottish Renal Registry. Encapsulating peritoneal sclerosis in the new millennium: A national cohort study. Clin J Am Soc Nephrol 2009;4:1222\u20139.","DOI":"10.2215\/CJN.01260209"},{"key":"2025120909184549810_j_pp-2016-0028_ref_014_w2aab3b7b7b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"14. Johnson DW, Cho Y, Livingston BE, Hawley CM, McDonald SP, Brown FG, et al. Encapsulating peritoneal sclerosis: Incidence, predictors, and outcomes. Kidney Int 2010;77:904\u201312.","DOI":"10.1038\/ki.2010.16"},{"key":"2025120909184549810_j_pp-2016-0028_ref_015_w2aab3b7b7b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"15. Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, et al. Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal Dialysis. Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: A quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol 2008;3:720\u20138.","DOI":"10.2215\/CJN.03630807"},{"key":"2025120909184549810_j_pp-2016-0028_ref_016_w2aab3b7b7b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"16. Kawanishi K, Honda K, Tsukada M, Oda H, Nitta K. Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis. Perit Dial Int 2013;33:242\u201351.","DOI":"10.3747\/pdi.2011.00270"},{"key":"2025120909184549810_j_pp-2016-0028_ref_017_w2aab3b7b7b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"17. Schaefer B, Bartosova M, Macher-Goeppinger S, Ujszaszi A, Wallwiener M, Nyarangi-Dix J, et al. Quantitative Histomorphometry of the Healthy Peritoneum. Sci Rep 2016;6:21344.","DOI":"10.1038\/srep21344"},{"key":"2025120909184549810_j_pp-2016-0028_ref_018_w2aab3b7b7b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"18. Braun N, Alscher DM, Fritz P, Edenhofer I, Kimmel M, Gaspert A, et al. Podoplanin-positive cells are a hallmark of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2011;26:1033\u201341.","DOI":"10.1093\/ndt\/gfq488"},{"key":"2025120909184549810_j_pp-2016-0028_ref_019_w2aab3b7b7b1b6b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"19. Yaginuma T, Yamamoto I, Yamamoto H, Mitome J, Tanno Y, Yokoyama K, et al. Increased lymphatic vessels in patients with encapsulating peritoneal sclerosis. Perit Dial Int 2012;32:617\u201327.","DOI":"10.3747\/pdi.2011.00096"},{"key":"2025120909184549810_j_pp-2016-0028_ref_020_w2aab3b7b7b1b6b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"20. Leblanc E, Sonoda Y, Narducci F, Ferron G, Querleu D. Laparoscopic staging of early ovarian carcinoma. Curr Opin Obstet Gynecol 2006;18:407\u201312.","DOI":"10.1097\/01.gco.0000233935.51801.48"},{"key":"2025120909184549810_j_pp-2016-0028_ref_021_w2aab3b7b7b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"21. Kikuchi H, Kamiya K, Hiramatsu Y, Miyazaki S, Yamamoto M, Ohta M, et al. Laparoscopic narrow-band imaging for the diagnosis of peritoneal metastasis in gastric cancer. Ann Surg Oncol 2014;21:3954\u201362.","DOI":"10.1245\/s10434-014-3781-8"},{"key":"2025120909184549810_j_pp-2016-0028_ref_022_w2aab3b7b7b1b6b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"22. Solass W, Sempoux C, Detlefsen S, Carr NJ, Bibeau F. Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: Proposal of the Peritoneal Regression Grading Score (PRGS). Pleura and Peritoneum 2016;1:99\u2013107.","DOI":"10.1515\/pp-2016-0011"},{"key":"2025120909184549810_j_pp-2016-0028_ref_023_w2aab3b7b7b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"23. Smith L, Collins JF, Morris M, Teele RL. Sclerosing encapsulating peritonitis associated with continuous ambulatory peritoneal dialysis: Surgical management. Am J Kidney Dis 1997;29:456\u201360.","DOI":"10.1016\/S0272-6386(97)90210-9"},{"key":"2025120909184549810_j_pp-2016-0028_ref_024_w2aab3b7b7b1b6b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"24. Sasaki K, Mizuno H, Iwamoto N, Imakita M, Yasuda K, Kimura T, et al. Laparoscopy Reveals a Diversity of Peritoneal Change in Patients with Long-Term Vintage of Peritoneal Dialysis. Blood Purif 2016;41:48\u201354.","DOI":"10.1159\/000439241"},{"key":"2025120909184549810_j_pp-2016-0028_ref_025_w2aab3b7b7b1b6b1ab2b1c25Aa","unstructured":"25. Michailova KN, Usunoff KG. Serosal membranes (pleura, peri- cardium, peritoneum). Normal structure, development and experimental pathology. Adv Anat Embryol Cell Biol 2006;183:1\u2013144."},{"key":"2025120909184549810_j_pp-2016-0028_ref_026_w2aab3b7b7b1b6b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"26. Osada S, Hamada C, Shimaoka T, Kaneko K, Horikoshi S, Tomino Y. Alterations in proteoglycan components and histopathology of the peritoneum in uraemic and peritoneal dialysis (PD) patients. Nephrol Dial Transplant 2009;24:3504\u201312.","DOI":"10.1093\/ndt\/gfp268"},{"key":"2025120909184549810_j_pp-2016-0028_ref_027_w2aab3b7b7b1b6b1ab2b1c27Aa","unstructured":"27. Yamada K, Miyahara Y, Hamaguchi K, Nakayama M, Nakano H, Nozaki O, et al. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Clin Nephrol 1994;42:354\u201361."},{"key":"2025120909184549810_j_pp-2016-0028_ref_028_w2aab3b7b7b1b6b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"28. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997;51:182\u20136.","DOI":"10.1038\/ki.1997.22"},{"key":"2025120909184549810_j_pp-2016-0028_ref_029_w2aab3b7b7b1b6b1ab2b1c29Aa","doi-asserted-by":"crossref","unstructured":"29. Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 1999;14:1541\u20139.","DOI":"10.1093\/ndt\/14.6.1541"},{"key":"2025120909184549810_j_pp-2016-0028_ref_030_w2aab3b7b7b1b6b1ab2b1c30Aa","doi-asserted-by":"crossref","unstructured":"30. Nakamoto H, Hamada C, Shimaoka T, Sekiguchi Y, Io H, Kaneko K, et al. Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients. J Artif Organs 2014;17:60\u20138.","DOI":"10.1007\/s10047-013-0741-1"},{"key":"2025120909184549810_j_pp-2016-0028_ref_031_w2aab3b7b7b1b6b1ab2b1c31Aa","unstructured":"31. Honda K, Nitta K, Horita S, Tsukada M, Itabashi M, Nihei H, et al. Histological Criteria for Encapsulating Peritoneal Sclerosis (EPS) in Continuous Ambulatory Peritoneal Dialysis (CAPD) patients. Adv Perit Dial 2003;19:169\u201375."},{"key":"2025120909184549810_j_pp-2016-0028_ref_032_w2aab3b7b7b1b6b1ab2b1c32Aa","unstructured":"32. Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int 2005;25 Suppl:S19\u2013S29."},{"key":"2025120909184549810_j_pp-2016-0028_ref_033_w2aab3b7b7b1b6b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"33. Garosi G, Di Paolo N, Sacchi G, Gaggiotti E. Sclerosing peritonitis: A nosological entity. Perit Dial Int 2005;25 Suppl:S110\u2013S112.","DOI":"10.1177\/089686080502503S28"},{"key":"2025120909184549810_j_pp-2016-0028_ref_034_w2aab3b7b7b1b6b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"34. Sherif AM, Yoshida H, Maruyama Y, Yamamoto H, Yokoyama K, Hosoya T, et al. Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis. Ther Apher Dial 2008;12:33\u201341.","DOI":"10.1111\/j.1744-9987.2007.00538.x"},{"key":"2025120909184549810_j_pp-2016-0028_ref_035_w2aab3b7b7b1b6b1ab2b1c35Aa","unstructured":"35. Braun N, Reimold F, Biegger D, Fritz P, Kimmel M, Ulmer C, et al. Fibrogenic growth factors in encapsulating peritoneal sclerosis. Nephron Clin Pract 2009;113:c88\u201395.34."},{"key":"2025120909184549810_j_pp-2016-0028_ref_036_w2aab3b7b7b1b6b1ab2b1c36Aa","unstructured":"36. Braun N, Fritz P, Ulmer C, Latus J, Kimmel M, Biegger D, et al. Histological criteria for encapsulating peritoneal sclerosis - a standardized approach. Plos One 2012;7:e48647."},{"key":"2025120909184549810_j_pp-2016-0028_ref_037_w2aab3b7b7b1b6b1ab2b1c37Aa","unstructured":"37. Tawada M, Ito Y, Hamada C, Honda K, Mizuno M, Suzuki Y, et al. Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients. Plos One 2016;11:e0154644."},{"key":"2025120909184549810_j_pp-2016-0028_ref_038_w2aab3b7b7b1b6b1ab2b1c38Aa","unstructured":"38. Kawanishi H, Moriishi M. Epidemiology of encapsulating peritoneal sclerosis in Japan. Perit Dial Int 2005;25 Suppl:S14\u2013S18."},{"key":"2025120909184549810_j_pp-2016-0028_ref_039_w2aab3b7b7b1b6b1ab2b1c39Aa","doi-asserted-by":"crossref","unstructured":"39. Kawaguchi Y, Saito A, Kawanishi H, Nakayama M, Miyazaki M, Nakamoto H, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: Diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int 2005;25:S83\u2013S95.","DOI":"10.1177\/089686080502504S12"},{"key":"2025120909184549810_j_pp-2016-0028_ref_040_w2aab3b7b7b1b6b1ab2b1c40Aa","doi-asserted-by":"crossref","unstructured":"40. Yokoyama K, Yoshida H, Matsuo N, Maruyama Y, Kawamura Y, Yamamoto R, et al. Serum beta2 microglobulin (beta2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients. Clin Nephrol 2008;69:121\u20136.","DOI":"10.5414\/CNP69121"},{"key":"2025120909184549810_j_pp-2016-0028_ref_041_w2aab3b7b7b1b6b1ab2b1c41Aa","unstructured":"41. Nakamura S, Miyazaki S, Sakai S, Morita T, Hirasawa Y, Niwa T. Localization of imidazolone in the peritoneum of capd patients: A factor for a loss of ultrafiltration. Am J Kidney Dis 2001;38 Suppl:S107\u2013S110."},{"key":"2025120909184549810_j_pp-2016-0028_ref_042_w2aab3b7b7b1b6b1ab2b1c42Aa","doi-asserted-by":"crossref","unstructured":"42. Numata M, Nakayama M, Hosoya T, Hoff CM, Holmes CJ, Schalling M, et al. Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients. Clin Nephrol 2004;62:455\u201360.","DOI":"10.5414\/CNP62455"},{"key":"2025120909184549810_j_pp-2016-0028_ref_043_w2aab3b7b7b1b6b1ab2b1c43Aa","doi-asserted-by":"crossref","unstructured":"43. Maruyama Y, Numata M, Nakayama M, Matsuo N, Nordfors L, Hosoya T, et al. Relationship between the -374T\/A receptor of advanced glycation end products gene polymorphism and peritoneal solute transport status at the initiation of peritoneal dialysis. Ther Apher Dial 2007;11:301\u20135.","DOI":"10.1111\/j.1744-9987.2007.00473.x"},{"key":"2025120909184549810_j_pp-2016-0028_ref_044_w2aab3b7b7b1b6b1ab2b1c44Aa","doi-asserted-by":"crossref","unstructured":"44. Yamamoto R, Otsuka Y, Nakayama M, Maruyama Y, Katoh N, Ikeda M, et al. Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment. Clin Exp Nephrol 2005;9:148\u201352.","DOI":"10.1007\/s10157-005-0349-8"},{"key":"2025120909184549810_j_pp-2016-0028_ref_045_w2aab3b7b7b1b6b1ab2b1c45Aa","doi-asserted-by":"crossref","unstructured":"45. Yamamoto T, Nagasue K, Okuno S, Yamakawa T. The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis. Perit Dial Int 2010;30:343\u201352.","DOI":"10.3747\/pdi.2008.00273"},{"key":"2025120909184549810_j_pp-2016-0028_ref_046_w2aab3b7b7b1b6b1ab2b1c46Aa","doi-asserted-by":"crossref","unstructured":"46. Fontana I, Bertocchi M, Santori G, Ferrari G, Barabani C, Valente U. Encapsulating peritoneal sclerosis after kidney transplantation a single-center experience from 1982 to 2010. Transplant Proc 2012;44:1918\u201321.","DOI":"10.1016\/j.transproceed.2012.06.010"},{"key":"2025120909184549810_j_pp-2016-0028_ref_047_w2aab3b7b7b1b6b1ab2b1c47Aa","doi-asserted-by":"crossref","unstructured":"47. Habib SM, Korte MR, Betjes MG. Lower mortality and inflammation from post-transplantation encapsulating peritoneal sclerosis compared to the classical form. Am J Nephrol 2013;37:223\u201330.","DOI":"10.1159\/000348267"},{"key":"2025120909184549810_j_pp-2016-0028_ref_048_w2aab3b7b7b1b6b1ab2b1c48Aa","doi-asserted-by":"crossref","unstructured":"48. Fieren MW, Betjes MG, Korte MR, Boer WH. Posttransplant encapsulating peritoneal sclerosis: A worrying new trend?. Perit Dial Int 2007;27:619\u201324.","DOI":"10.1177\/089686080702700603"},{"key":"2025120909184549810_j_pp-2016-0028_ref_049_w2aab3b7b7b1b6b1ab2b1c49Aa","doi-asserted-by":"crossref","unstructured":"49. Korte MR, Habib SM, Lingsma H, Weimar W, Betjes MG. Posttransplantation encapsulating peritoneal sclerosis contributes significantly to mortality after kidney transplantation. Am J Transplant 2011;11:599\u2013605.","DOI":"10.1111\/j.1600-6143.2010.03434.x"},{"key":"2025120909184549810_j_pp-2016-0028_ref_050_w2aab3b7b7b1b6b1ab2b1c50Aa","doi-asserted-by":"crossref","unstructured":"50. Khanna A, Plummer M, Bromberek C, Bresnahan B, Hariharan S. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int 2002;62:2257\u201363.","DOI":"10.1046\/j.1523-1755.2002.00668.x"},{"key":"2025120909184549810_j_pp-2016-0028_ref_051_w2aab3b7b7b1b6b1ab2b1c51Aa","unstructured":"51. Latus J, Habib SM, Kitterer D, Korte MR, Ulmer C, Fritz P, et al., European EPS study group. Histological and clinical findings in patients with post-transplantation and classical encapsulating peritoneal sclerosis: A European multicenter study. Plos One 2014;29:e106511."},{"key":"2025120909184549810_j_pp-2016-0028_ref_052_w2aab3b7b7b1b6b1ab2b1c52Aa","doi-asserted-by":"crossref","unstructured":"52. Sampimon DE, Korte MR, Barreto DL, Vlijm A, De Waart R, Struijk DG, et al. Early diagnostic markers for encapsulating peritoneal sclerosis: A case-control study. Perit Dial Int 2010;30:163\u20139.","DOI":"10.3747\/pdi.2009.00022"},{"key":"2025120909184549810_j_pp-2016-0028_ref_053_w2aab3b7b7b1b6b1ab2b1c53Aa","doi-asserted-by":"crossref","unstructured":"53. Wright B, Summers A, Fenner J, Gillott R, Hutchinson CE, Spencer PA, et al. Initial observations using a novel \u201ccine\u201d magnetic resonance imaging technique to detect changes in abdominal motion caused by encapsulating peritoneal sclerosis. Perit Dial Int 2011;31:287\u201390.","DOI":"10.3747\/pdi.2010.00078"},{"key":"2025120909184549810_j_pp-2016-0028_ref_054_w2aab3b7b7b1b6b1ab2b1c54Aa","doi-asserted-by":"crossref","unstructured":"54. Trigka K, Dousdampanis P, Chu M, Khan S, Ahmad M, Bargman JM, et al. Encapsulating peritoneal sclerosis: A single-center experience and review of the literature. Int Urol Nephrol 2011;43:519\u201326.","DOI":"10.1007\/s11255-010-9848-y"},{"key":"2025120909184549810_j_pp-2016-0028_ref_055_w2aab3b7b7b1b6b1ab2b1c55Aa","doi-asserted-by":"crossref","unstructured":"55. Gupta S, Woodrow G. Successful treatment of fulminant encapsulating peritoneal sclerosis following fungal peritonitis with tamoxifen. Clin Nephrol 2007;68:125\u20139.","DOI":"10.5414\/CNP68125"},{"key":"2025120909184549810_j_pp-2016-0028_ref_056_w2aab3b7b7b1b6b1ab2b1c56Aa","doi-asserted-by":"crossref","unstructured":"56. Wong YY, Wong PN, Mak SK, Chan SF, Cheuk YY, Ho LY, et al. Persistent sterile peritoneal inflammation after catheter removal for refractory bacterial peritonitis predicts full-blown encapsulating peritoneal sclerosis. Perit Dial Int 2013;33:507\u201314.","DOI":"10.3747\/pdi.2012.00281"},{"key":"2025120909184549810_j_pp-2016-0028_ref_057_w2aab3b7b7b1b6b1ab2b1c57Aa","doi-asserted-by":"crossref","unstructured":"57. Schmitt CP, Aufricht C. Is there such a thing as biocompatible peritoneal dialysis fluid?. Pediatr Nephrol 2016. DOI:10.1007\/s00467-016-3461-y.","DOI":"10.1007\/s00467-016-3461-y"},{"key":"2025120909184549810_j_pp-2016-0028_ref_058_w2aab3b7b7b1b6b1ab2b1c58Aa","doi-asserted-by":"crossref","unstructured":"58. Davies SJ. Peritoneal solute transport and inflammation. Am J Kidney Dis 2014;64:978\u201386.","DOI":"10.1053\/j.ajkd.2014.06.030"},{"key":"2025120909184549810_j_pp-2016-0028_ref_059_w2aab3b7b7b1b6b1ab2b1c59Aa","doi-asserted-by":"crossref","unstructured":"59. Cho Y, Johnson DW, Vesey DA, Hawley CM, Pascoe EM, Clarke M, et al. Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrol 2014;15:8.","DOI":"10.1186\/1471-2369-15-8"},{"key":"2025120909184549810_j_pp-2016-0028_ref_060_w2aab3b7b7b1b6b1ab2b1c60Aa","doi-asserted-by":"crossref","unstructured":"60. Van Esch S, Struijk DG, Krediet RT. The Natural Time Course of Membrane Alterations During Peritoneal Dialysis Is Partly Altered by Peritonitis. Perit Dial Int 2016;36:448\u201356.","DOI":"10.3747\/pdi.2014.00215"},{"key":"2025120909184549810_j_pp-2016-0028_ref_061_w2aab3b7b7b1b6b1ab2b1c61Aa","doi-asserted-by":"crossref","unstructured":"61. Van Esch S, Van Diepen AT, Struijk DG, Krediet RT. The Mutual Relationship Between Peritonitis and Peritoneal Transport. Perit Dial Int 2016;36:33\u201342.","DOI":"10.3747\/pdi.2014.00115"},{"key":"2025120909184549810_j_pp-2016-0028_ref_062_w2aab3b7b7b1b6b1ab2b1c62Aa","doi-asserted-by":"crossref","unstructured":"62. Bell\u00f3n T, Mart\u00ednez V, Lucendo B, Del Peso G, Castro MJ, Aroeira LS, et al. Alternative activation of macrophages in human peritoneum: Implications for peritoneal fibrosis. Nephrol Dial Transplant 2011;26:2995\u20133005.","DOI":"10.1093\/ndt\/gfq771"},{"key":"2025120909184549810_j_pp-2016-0028_ref_063_w2aab3b7b7b1b6b1ab2b1c63Aa","doi-asserted-by":"crossref","unstructured":"63. Ahmad S, North BV, Qureshi A, Malik A, Bhangal G, Tarzi RM, et al. CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosis. Eur J Clin Invest 2010;40:1067\u20131073.","DOI":"10.1111\/j.1365-2362.2010.02353.x"},{"key":"2025120909184549810_j_pp-2016-0028_ref_064_w2aab3b7b7b1b6b1ab2b1c64Aa","doi-asserted-by":"crossref","unstructured":"64. Goodlad C, Tam FW, Ahmad S, Bhangal G, North BV, Brown EA. Dialysate cytokine levels do not predict encapsulating peritoneal sclerosis. Perit Dial Int 2014;34:594\u2013604.","DOI":"10.3747\/PDI.2012.00305"},{"key":"2025120909184549810_j_pp-2016-0028_ref_065_w2aab3b7b7b1b6b1ab2b1c65Aa","unstructured":"65. Sanz AB, Aroeira LS, Bellon T, Del Peso G, Jimenez-Heffernan J, Santamaria B, et al. TWEAK promotes peritoneal inflammation. Plos One 2014;9:e90399."},{"key":"2025120909184549810_j_pp-2016-0028_ref_066_w2aab3b7b7b1b6b1ab2b1c66Aa","doi-asserted-by":"crossref","unstructured":"66. Rodrigues-D\u00edez R, Aroeira LS, Orejudo M, Bajo MA, Heffernan JJ, Rodrigues-D\u00edez RR, et al. IL-17A is a novel player in dialysis-induced peritoneal damage. Kidney Int 2014;86:303\u2013315.","DOI":"10.1038\/ki.2014.33"},{"key":"2025120909184549810_j_pp-2016-0028_ref_067_w2aab3b7b7b1b6b1ab2b1c67Aa","doi-asserted-by":"crossref","unstructured":"67. Zhou Q, Bajo MA, Del Peso G, Yu X, Selgas R. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int 2016;90:515\u201324.","DOI":"10.1016\/j.kint.2016.03.040"},{"key":"2025120909184549810_j_pp-2016-0028_ref_068_w2aab3b7b7b1b6b1ab2b1c68Aa","doi-asserted-by":"crossref","unstructured":"68. Twardowski ZJ, Nolph KO, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull 1987;7:138\u201347.","DOI":"10.1177\/089686088700700306"},{"key":"2025120909184549810_j_pp-2016-0028_ref_069_w2aab3b7b7b1b6b1ab2b1c69Aa","doi-asserted-by":"crossref","unstructured":"69. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998;9:1285\u20132.","DOI":"10.1681\/ASN.V971285"},{"key":"2025120909184549810_j_pp-2016-0028_ref_070_w2aab3b7b7b1b6b1ab2b1c70Aa","doi-asserted-by":"crossref","unstructured":"70. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG. Meta- analysis: Peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006;17:2591\u20138.","DOI":"10.1681\/ASN.2006030194"},{"key":"2025120909184549810_j_pp-2016-0028_ref_071_w2aab3b7b7b1b6b1ab2b1c71Aa","doi-asserted-by":"crossref","unstructured":"71. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al. Survival of functionally anuric patients on automated peritoneal dialysis: The European APD Outcome Study. J Am Soc Nephrol 2003;14:2948\u201357.","DOI":"10.1097\/01.ASN.0000092146.67909.E2"},{"key":"2025120909184549810_j_pp-2016-0028_ref_072_w2aab3b7b7b1b6b1ab2b1c72Aa","doi-asserted-by":"crossref","unstructured":"72. Johnson DW, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2010;25:1973\u201379.","DOI":"10.1093\/ndt\/gfp780"},{"key":"2025120909184549810_j_pp-2016-0028_ref_073_w2aab3b7b7b1b6b1ab2b1c73Aa","doi-asserted-by":"crossref","unstructured":"73. Cnossen TT, Usvyat L, Kotanko P, Van Der Sande FM, Kooman JP, Carter M, et al. Comparison of outcomes on continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis: Results from a USA database. Perit Dial Int 2011;31:679\u201384.","DOI":"10.3747\/pdi.2010.00004"},{"key":"2025120909184549810_j_pp-2016-0028_ref_074_w2aab3b7b7b1b6b1ab2b1c74Aa","doi-asserted-by":"crossref","unstructured":"74. Qi H, Xu C, Yan H, Ma J. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: A meta-analysis of randomized controlled trials. Perit Dial Int 2011;31:179\u201388.","DOI":"10.3747\/pdi.2009.00264"},{"key":"2025120909184549810_j_pp-2016-0028_ref_075_w2aab3b7b7b1b6b1ab2b1c75Aa","doi-asserted-by":"crossref","unstructured":"75. Cho Y, Johnson DW, Badve S, Craig JC, Strippoli GF, Wiggins KJ. Impact of icodextrin on clinical outcomes in peritoneal dialysis: A systematic review of randomized controlled trials. Nephrol Dial Transplant 2013;28:1899\u2013907.","DOI":"10.1093\/ndt\/gft050"},{"key":"2025120909184549810_j_pp-2016-0028_ref_076_w2aab3b7b7b1b6b1ab2b1c76Aa","unstructured":"76. Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev 2014;27:CD007554."},{"key":"2025120909184549810_j_pp-2016-0028_ref_077_w2aab3b7b7b1b6b1ab2b1c77Aa","doi-asserted-by":"crossref","unstructured":"77. Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, et al., balANZ Trial Investigators. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol 2012;23:1097\u2013107.","DOI":"10.1681\/ASN.2011121201"},{"key":"2025120909184549810_j_pp-2016-0028_ref_078_w2aab3b7b7b1b6b1ab2b1c78Aa","doi-asserted-by":"crossref","unstructured":"78. Lai KN, Lam MF, Leung JC, Chan LY, Lam CW, Chan IH, et al. A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products. Perit Dial Int 2012;32:280\u201391.","DOI":"10.3747\/pdi.2010.00176"},{"key":"2025120909184549810_j_pp-2016-0028_ref_079_w2aab3b7b7b1b6b1ab2b1c79Aa","doi-asserted-by":"crossref","unstructured":"79. Sherif AM, Nakayama M, Maruyama Y, Yoshida H, Yamamoto H, Yokoyama K, et al. Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients. Nephrol Dial Transplant 2006;21:1675\u201381.","DOI":"10.1093\/ndt\/gfl054"},{"key":"2025120909184549810_j_pp-2016-0028_ref_080_w2aab3b7b7b1b6b1ab2b1c80Aa","doi-asserted-by":"crossref","unstructured":"80. Jim\u00e9nez-Heffernan JA, Perna C, Auxiliadora Bajo M, Luz Picazo M, Del Peso G, Aroeira L, et al. Tissue distribution of hyalinazing vasculopathy lesions in peritoneal dialysis patients: An autopsy study. Pathol Res Pract 2008;204:563\u20137.","DOI":"10.1016\/j.prp.2008.01.014"},{"key":"2025120909184549810_j_pp-2016-0028_ref_081_w2aab3b7b7b1b6b1ab2b1c81Aa","unstructured":"81. Del Peso G, Jim\u00e9nez-Heffernan JA, Bajo MA, Aroeira LS, Aguilera A, Fern\u00e1ndez-Perp\u00e9n A, et al. Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport. Kidney Int Suppl 2008;108:S26\u2013S33."},{"key":"2025120909184549810_j_pp-2016-0028_ref_082_w2aab3b7b7b1b6b1ab2b1c82Aa","doi-asserted-by":"crossref","unstructured":"82. Sawai A, Ito Y, Mizuno M, Suzuki Y, Toda S, Ito I, et al. Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients. Nephrol Dial Transplant 2011;26:2322\u201332.","DOI":"10.1093\/ndt\/gfq702"},{"key":"2025120909184549810_j_pp-2016-0028_ref_083_w2aab3b7b7b1b6b1ab2b1c83Aa","doi-asserted-by":"crossref","unstructured":"83. Aroeira LS, Aguilera A, Selgas R, Ram\u00edrez-Huesca M, P\u00e9rez-Lozano ML, Cirugeda A, et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: Role of vascular endothelial growth factor. Am J Kidney Dis 2005;46:938\u201348.","DOI":"10.1053\/j.ajkd.2005.08.011"},{"key":"2025120909184549810_j_pp-2016-0028_ref_084_w2aab3b7b7b1b6b1ab2b1c84Aa","doi-asserted-by":"crossref","unstructured":"84. Boulanger E, Grossin N, Wautier MP, Taamma R, Wautier JL. Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation. Kidney Int 2007;71:126\u201333.","DOI":"10.1038\/sj.ki.5002016"},{"key":"2025120909184549810_j_pp-2016-0028_ref_085_w2aab3b7b7b1b6b1ab2b1c85Aa","doi-asserted-by":"crossref","unstructured":"85. L\u00f3pez-Cabrera M. Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis. Adv Med 2014;2014:473134.","DOI":"10.1155\/2014\/473134"},{"key":"2025120909184549810_j_pp-2016-0028_ref_086_w2aab3b7b7b1b6b1ab2b1c86Aa","doi-asserted-by":"crossref","unstructured":"86. Chen YT, Chang YT, Pan SY, Chou YH, Chang FC, Yeh PY, et al. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol 2014;25:2847\u201358.","DOI":"10.1681\/ASN.2013101079"},{"key":"2025120909184549810_j_pp-2016-0028_ref_087_w2aab3b7b7b1b6b1ab2b1c87Aa","unstructured":"87. Mizutani M, Ito Y, Mizuno M, Nishimura H, Suzuki Y, Hattori R, et al. Connective tissue growth factor (CTGF\/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol 2010;298:F721\u2013F733."},{"key":"2025120909184549810_j_pp-2016-0028_ref_088_w2aab3b7b7b1b6b1ab2b1c88Aa","doi-asserted-by":"crossref","unstructured":"88. Ni J, Verbavatz JM, Rippe A, Boisd\u00e9 I, Moulin P, Rippe B, et al. Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int 2006;69:1518\u201325.","DOI":"10.1038\/sj.ki.5000285"},{"key":"2025120909184549810_j_pp-2016-0028_ref_089_w2aab3b7b7b1b6b1ab2b1c89Aa","doi-asserted-by":"crossref","unstructured":"89. Morelle J, Sow A, Hautem N, Bouzin C, Crott R, Devuyst O, et al. Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis. J Am Soc Nephrol 2015;26:2521\u201333.","DOI":"10.1681\/ASN.2014090939"},{"key":"2025120909184549810_j_pp-2016-0028_ref_090_w2aab3b7b7b1b6b1ab2b1c90Aa","doi-asserted-by":"crossref","unstructured":"90. Kinashi H, Ito Y, Mizuno M, Suzuki Y, Terabayashi T, Nagura F, et al. TGF-\u03b21 promotes lymphangiogenesis during peritoneal fibrosis. J Am Soc Nephrol 2013;24:1627\u201342.","DOI":"10.1681\/ASN.2012030226"},{"key":"2025120909184549810_j_pp-2016-0028_ref_091_w2aab3b7b7b1b6b1ab2b1c91Aa","doi-asserted-by":"crossref","unstructured":"91. Ayuzawa N, Ishibashi Y, Takazawa Y, Kume H, Fujita T. Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: Recent clinical practice in Japan. Perit Dial Int 2012;32:159\u201367.","DOI":"10.3747\/pdi.2010.00234"},{"key":"2025120909184549810_j_pp-2016-0028_ref_092_w2aab3b7b7b1b6b1ab2b1c92Aa","doi-asserted-by":"crossref","unstructured":"92. Hamada C, Honda K, Kawanishi K, Nakamoto H, Ito Y, Sakurada T, et al. Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution. J Artif Organs 2015;18:243\u201350.","DOI":"10.1007\/s10047-015-0822-4"},{"key":"2025120909184549810_j_pp-2016-0028_ref_093_w2aab3b7b7b1b6b1ab2b1c93Aa","doi-asserted-by":"crossref","unstructured":"93. Del Peso G, Jim\u00e9nez-Heffernan JA, Selgas R, Rem\u00f3n C, Ossorio M, Fern\u00e1ndez-Perp\u00e9n A, et al. Biocompatible Dialysis Solutions Preserve Peritoneal Mesothelial Cell and Vessel Wall Integrity. A Case-Control Study on Human Biopsies. Perit Dial Int 2016;36:129\u201334.","DOI":"10.3747\/pdi.2014.00038"},{"key":"2025120909184549810_j_pp-2016-0028_ref_094_w2aab3b7b7b1b6b1ab2b1c94Aa","doi-asserted-by":"crossref","unstructured":"94. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al., Euro Balance Trial Group. The Euro-Balance Trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004;66:408\u201318.","DOI":"10.1111\/j.1523-1755.2004.00747.x"},{"key":"2025120909184549810_j_pp-2016-0028_ref_095_w2aab3b7b7b1b6b1ab2b1c95Aa","doi-asserted-by":"crossref","unstructured":"95. Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, et al., balANZ Trial Investigators. The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: The balANZ trial. Nephrol Dial Transplant 2012;27:4445\u201353.","DOI":"10.1093\/ndt\/gfs314"},{"key":"2025120909184549810_j_pp-2016-0028_ref_096_w2aab3b7b7b1b6b1ab2b1c96Aa","doi-asserted-by":"crossref","unstructured":"96. Cho Y, Johnson DW, Badve SV, Craig JC, Strippoli GF, Wiggins KJ. The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int 2013;84:969\u201379.","DOI":"10.1038\/ki.2013.190"},{"key":"2025120909184549810_j_pp-2016-0028_ref_097_w2aab3b7b7b1b6b1ab2b1c97Aa","doi-asserted-by":"crossref","unstructured":"97. Yohanna S, Alkatheeri AM, Brimble SK, McCormick B, Iansavitchous A, Blake PG, et al. Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: ASystematic Review and Meta-Analysis. Clin J Am Soc Nephrol 2015;10:1380\u20138.","DOI":"10.2215\/CJN.05410514"},{"key":"2025120909184549810_j_pp-2016-0028_ref_098_w2aab3b7b7b1b6b1ab2b1c98Aa","doi-asserted-by":"crossref","unstructured":"98. Wang J, Zhu N, Yuan W. Effect of neutral pH and low-glucose degradation product-containing peritoneal dialysis solution on residual renal function in peritoneal dialysis patients: A meta-analysis. Nephron 2015;129:155\u201363.","DOI":"10.1159\/000368235"},{"key":"2025120909184549810_j_pp-2016-0028_ref_099_w2aab3b7b7b1b6b1ab2b1c99Aa","doi-asserted-by":"crossref","unstructured":"99. Nakayama M, Miyazaki M, Honda K, Kasai K, Tomo T, Nakamoto H, et al. Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: The NEXT-PD study. Perit Dial Int 2014;34:766\u201374.","DOI":"10.3747\/pdi.2013.00074"},{"key":"2025120909184549810_j_pp-2016-0028_ref_100_w2aab3b7b7b1b6b1ab2b1d100Aa","unstructured":"100. Viglino G, Neri L, Barbieri S. Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy. Kidney Int. Suppl 2008;108:S52\u2013S55."},{"key":"2025120909184549810_j_pp-2016-0028_ref_101_w2aab3b7b7b1b6b1ab2b1d101Aa","doi-asserted-by":"crossref","unstructured":"101. Kawanishi H, Hashimoto Y, Nakamoto H, Nakayama M, Tranaeus A. Combination therapy with peritoneal dialysis and hemodialysis. Perit Dial Int 2006;26:150\u20134.","DOI":"10.1177\/089686080602600205"},{"key":"2025120909184549810_j_pp-2016-0028_ref_102_w2aab3b7b7b1b6b1ab2b1d102Aa","unstructured":"102. Working Group Committee for Preparation of Guidelines for Peritoneal Dialysis, Japanese Society for Dialysis Therapy. Japanese Society for Dialysis Therapy. 2009 Japanese Society for Dialysis Therapy guidelines for peritoneal dialysis. Ther Apher Dial 2010;14:489\u2013504."},{"key":"2025120909184549810_j_pp-2016-0028_ref_103_w2aab3b7b7b1b6b1ab2b1d103Aa","doi-asserted-by":"crossref","unstructured":"103. Nakayama M, Terawaki H. Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: Update from Japan. Int J Urol 2014;21:755\u201361.","DOI":"10.1111\/iju.12445"},{"key":"2025120909184549810_j_pp-2016-0028_ref_104_w2aab3b7b7b1b6b1ab2b1d104Aa","doi-asserted-by":"crossref","unstructured":"104. Solass W, Horvath P, Struller F, K\u00f6Nigsrainer I, Beckert S, K\u00f6Nigsrainer A, et al. Functional vascular anatomy of the peritoneum in health and disease. Pleura and Peritoneum 2016;1:145\u201358.","DOI":"10.1515\/pp-2016-0015"},{"key":"2025120909184549810_j_pp-2016-0028_ref_105_w2aab3b7b7b1b6b1ab2b1d105Aa","doi-asserted-by":"crossref","unstructured":"105. Lattouf R, Younes R, Lutomski D, Naaman N, Godeau G, Senni K, et al. Picrosirius red staining: A useful tool to appraise collagen networks in normal and pathological tissues. J Histochem Cytochem 2014;62:751\u20138.","DOI":"10.1369\/0022155414545787"},{"key":"2025120909184549810_j_pp-2016-0028_ref_106_w2aab3b7b7b1b6b1ab2b1d106Aa","doi-asserted-by":"crossref","unstructured":"106. Krajewska M, Smith LH, Rong J, Huang X, Hyer ML, Zeps N, et al. Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections. J Histochem Cytochem 2009;57:649\u201363.","DOI":"10.1369\/jhc.2009.952812"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/2\/1\/article-p3.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0028\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0028\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T09:38:52Z","timestamp":1765273132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0028\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,11]]},"published-print":{"date-parts":[[2017,3,1]]}},"alternative-id":["10.1515\/pp-2016-0028"],"URL":"https:\/\/doi.org\/10.1515\/pp-2016-0028","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"value":"2364-768X","type":"electronic"},{"value":"2364-7671","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,1]]}}}